Press Releases
Breast Cancer
-
Cytotoxic Therapies Market Estimated to Decline Marginally by 2017
MarketResearch.com has announced the addition of the new report "Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion," to their collection of Generics Drugs...
-
Ed Randall's Fans for the Cure Launches "Stadium of Champions" to Help Strike Out Prostate Cancer; Campaign Strives to "Sell Out" a Virtual Stadium of Fans
Charity's stadium seats 3,510 fans. NEW YORK, NY, May 21, 2012 /24-7PressRelease/ -- Ed Randall's Fans for the Cure ( www.fans4thecure.org ) today launched its "Stadium of Champions" membership drive, designed to increase awareness of prostate...
-
Generex Augments Antigen Express Scientific Advisory Board
Generex Augments Antigen Express Scientific Advisory Board Drs. Ian Krop, MD, PhD and Nuhad Ibrahim, MD join SAB PR Newswire WORCESTER, Mass. and TORONTO , May 18, 2012 /PRNewswire/ -- Generex Biotechnology Corporation...
-
Medivation and Astellas Announce Enzalutamide (Formerly MDV3100) Data to Be Presented at ASCO Annual Meeting 2012
Medivation Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. today announced that six abstracts related to enzalutamide (formerly MDV3100) will be presented at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL...
-
Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting PR Newswire HATFIELD, England , May 18, 2012 /PRNewswire/ -- Eisai announced today that 12 abstracts highlighting new study results...
-
Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting PR Newswire WOODCLIFF LAKE, N.J. , May 17, 2012 /PRNewswire/ -- Eisai announced today that 15 abstracts highlighting new study results...
-
Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer
Leading Researchers Address Hope For Early Detection and Treatments For Lung Cancer PR Newswire LUNGevity, Nation's Largest Lung Cancer-focused Nonprofit, Funds Critical, Encouraging Research WASHINGTON , May 17, 2012 /PRNewswire-USNewswire/...
-
Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer
Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer -- Results from Phase 1 clinical trial of EP-100 to be presented at ASCO -- PR Newswire...
-
Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine Drs. Keith L. Knutson, PhD and James J. Mule join SAB PR Newswire WORCESTER, Mass. and TORONTO , May 17, 2012 /PRNewswire/...
-
New Data from Silence's Atu027 Anticancer Trial Published at ASCO
New Data from Silence's Atu027 Anticancer Trial Published at ASCO PR Newswire LONDON , May 17, 2012 /PRNewswire/ -- - Atu027, a First in Class RNAi Therapy, Demonstrates Potential - Antitumour Activity in Cancer Patients and...
-
Collaborative study looks for clues on hard-to-treat breast cancer
Some types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy. Called triple negative...
-
Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting
Genomic Health Announces Presentation of Eighteen Studies Highlighting Progress in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology 2012 Annual Meeting PR Newswire REDWOOD CITY, Calif. , May 16, 2012...
-
Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 LUX-Lung 3 clinical trial data selected for late-breaking oral presentation PR Newswire ...
-
Ford eNews - May 16, 2012
Ford eNews - May 16, 2012 PR Newswire DEARBORN, Mich. , May 16, 2012 /PRNewswire/ -- Stealthy SHO gets its speed on The 2013 Ford Taurus SHO with Performance Package is the ride of choice for anyone looking to burn rubber after...
-
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research
Lung Cancer Alliance Announces Important First Step Cleared For More Federal Funding For Lung Cancer Research PR Newswire Additional $10.5 million approved in FY2013 Department of Defense Lung Cancer Research Program for...
Follow us
What people say
Our Partners
© 2005-2012